Continuous Flow Reactor
Multiphase Slurry Reactor

Multiphase Slurry Flow Reactors

(High-Solids, High-Throughput Continuous Processing)

Specialty

Designed for liquid–solid–gas and liquid–solid reactions with exceptionally high solid loading where conventional flow systems fail. Engineered hydrodynamics eliminate settling and clogging.

Key CapabilitiesBest Suited For
  • Handles up to 50% solid content
  • Throughput up to 100,000+ TPA
  • No settling, no clogging
  • Continuous crystallizing & fouling systems
  • Superior thermal control
  • Nitrations with solids
  • Hydrogenations with slurry catalysts
  • High-exotherm reactions

Grignard Reactor

Grignard Flow Reactors

(Safe Organometallic Chemistry)

Specialty

Safe continuous execution of highly reactive organometallic chemistry.

Key CapabilitiesBest Suited For
  • Capacity up to 6,000 TPA
  • Tight temperature control
  • Controlled initiation & quenching
  • Reduced runaway risk
  • Grignard reagent formation
  • Organometallic transformations
Critical Advantage:
Enables reactions unsafe in batch.

Microchannel Reactor

Microchannel Reactors

(Extreme Heat Removal, Ultimate Precision)

Specialty

Ultra-high surface-area-to-volume ratio enabling extreme heat removal and precision.

Key CapabilitiesBest Suited For
  • Photo-catalytic reactions supported
  • Millisecond–second residence times
  • Highest selectivity
  • Highly exothermic reactions
  • Fast kinetics chemistry
  • Lab to pilot development

Rectangular Reactor

MIC (Micro Insert Channel) Reactors with Static Mixers

(Workhorse for Large-Scale Continuous Chemistry)

Specialty

High-efficiency mixing with precise residence-time control for fast and highly exothermic reactions.

Key CapabilitiesBest Suited For
  • Throughput up to 20,000+ TPA
  • Excellent heat & mass transfer
  • Modular scale-up
  • Very low back-mixing → high selectivity
  • Chlorination
  • Sulfonation
  • Diazotization
  • Friedel–Crafts reactions
Differentiator:
Optimized static mixer geometry based on reaction kinetics.

Loop Reactor

Loop Reactors

(Gas–Liquid Reactions with Superior Control)

Specialty

Continuous circulation reactor designed for gas–liquid and highly exothermic reactions.

Key CapabilitiesBest Suited For
  • Excellent temperature uniformity
  • High gas utilization efficiency
  • Industrial scalability
  • Chlorination
  • Hydrogenation
  • Oxidation reactions
Safety Advantage:
Smaller reactive volume + controlled circulation = safer than batch.

Crystallizer Reactor

Continuous Reaction Crystallizers

(From Reaction to Solid — Continuously)

Specialty

Integrated reaction + crystallization under continuous control.

Key CapabilitiesBest Suited For
  • Narrow particle size distribution
  • Consistent crystal habit
  • Reduced downstream load
  • APIs
  • Intermediates
  • Specialty chemicals

Fixed Bed Reactor

Fixed Bed Continuous Hydrogenation Reactors

(Catalyst Stability + Continuous Productivity)

Specialty

Continuous hydrogenation with immobilized catalysts ensuring long catalyst life and clean output.

Key CapabilitiesBest Suited For
  • Stable long-term catalyst performance
  • Minimal catalyst handling
  • High hydrogen mass transfer
  • Low impurity formation
  • Pharma hydrogenations
  • Selective reductions
  • High purity chemicals
Subscribe Icon

Subscribe for flow updates

Get the latest insights, technology news, and case studies.


    ROI Icon

    Calculate your flow ROI

    Estimate savings and operational efficiencies with continuous flow.

    Go to calculator
    WhatsApp Icon

    Sign up for WhatsApp updates

    Share your process for one-on-one discussion.

    Start a conversation

    Contact Table

    Medical Devices Expert

    Connect with our Medical Devices Specialist for product guidance, technical support, and partnership inquiries.

    Name

    Contact Number

    Email

    Disha Desai +91 96194 94942 disha.desai@rifapharma.com


        Contact us

        Let us know how can we help?






        Disha Desai

        Medical Devices and
Packaging Solutions

        Ms. Desai has masterfully elevated the valuation of the Packaging and Medical Devices division, breaking barriers and unlocking new opportunities. She is an invaluable force with over 10+ years of expertise and a portfolio of 30+ customer companies. Her relentless hustle, strategic vision, and unwavering determination not only seize opportunities but create them, driving unprecedented growth and success.

        Ms Ujwala Parkhe

        Veterinary APIs & Premixes, Nutraceutical APIs

        Ms. Ujwala is a razor-sharp professional with an unwavering focus on delivering results. With deep expertise in the veterinary premix market, she ensures every promise and goal is achieved. Her tenacity, proficiency with active ingredients, and strategic foresight set her apart. Leading sales and new developments at Rifa Pharma, she drives innovation, sustainability, and impactful growth, making her a trusted advisor and partner in success.

        Dr Sanjay Loomba

        CEO at Rifa Pharma

        Our CEO and partner - Dr. Sanjay Loomba, a trauma surgeon and visionary leader, brings over 18 years of expertise in healthcare and the pharmaceutical industry. He has been instrumental in establishing advanced manufacturing facilities and optimising procurement for global markets. Currently, at Rifa Pharma, he focuses on driving innovation, enhancing operational excellence, promoting sustainability, and delivering patient-centric solutions that address the evolving needs of the healthcare sector.

        Neha Thakore

        Managing Partner at Rifa Pharma

        Neha is a dynamic and accomplished leader at Rifa Pharma, bringing over 25 years of expertise in the pharmaceutical industry, with a strong focus on operations. She is highly proficient in business development and regulatory affairs, successfully securing global approvals and driving impactful market expansion. As the Vice Chairperson of the IDMA Bulk Drug Committee, she plays a pivotal role in enhancing industry influence. Her comprehensive expertise extends across corporate governance, ESG strategy, and stakeholder engagement, ensuring sustainable growth and unwavering compliance excellence..

        Anant Thakore

        Founder

        Anant Thakore embodies resilience, vision, and leadership.Stepping in during a critical phase, he revolutionized the company,driving it to a remarkable $60 million indenting enterprise.A true pioneer in India’s pharmaceutical landscape,he played a crucial role in advancing anti-tuberculosis and antibiotic manufacturing. His groundbreaking achievements include becoming the first indigenous manufacturer of corticosteroids,solidifying his legacy as a transformative force in the industry.